Functional drug-releasing polymer nano-composites for preventing medical device infection and encrustation. By developing new methodologies for producing functional biomaterials, this research will benefit Australia by continuing our high profile in this research field and by producing economic benefits arising from development and export of materials technologies to the major user groups in USA and Europe. With our demonstrated linkages with Australian based biomaterials developers at CSIRO an ....Functional drug-releasing polymer nano-composites for preventing medical device infection and encrustation. By developing new methodologies for producing functional biomaterials, this research will benefit Australia by continuing our high profile in this research field and by producing economic benefits arising from development and export of materials technologies to the major user groups in USA and Europe. With our demonstrated linkages with Australian based biomaterials developers at CSIRO and University of Queensland, as well as with companies involved in the commercialisation of polyurethane based medical devices (Aortech P/L), this group is well placed to continue the research at a more applied level once the early basic stage is complete.Read moreRead less
Novel Antimicrobial Biomaterials. There is a clear need for new materials that repel bacteria. Infections associated with biomaterials incur a high cost in terms of human health and well being, but such infections also increase the burden on the health care system by extending hospital stays and significantly elevating costs. The cost of a catheter-related blood stream infection is around $50,000 for patients in intensive care units. If all medical devices are considered, the cost of related inf ....Novel Antimicrobial Biomaterials. There is a clear need for new materials that repel bacteria. Infections associated with biomaterials incur a high cost in terms of human health and well being, but such infections also increase the burden on the health care system by extending hospital stays and significantly elevating costs. The cost of a catheter-related blood stream infection is around $50,000 for patients in intensive care units. If all medical devices are considered, the cost of related infections is then approximately $20 billion. The technology proposed here has the potential to reduce biomaterial related infection rates, improve health care and reduce health care costs. Read moreRead less